- Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
-
Alonso R, Eizaguirre MB, Zavala L, Pita C, Silva B, Garcea O
- KMID: 2424176
- J Clin Neurol.
- 2018 Oct;14(4):487-491.
- doi: 10.3988/jcn.2018.14.4.487
BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Information Processing Speed in Clinical and Social Support Variables of Patients with Multiple Sclerosis
-
Eizaguirre MB, Vanotti S, Merino A, Yastremiz , Silva B, Alonso R, Garcea O
- KMID: 2424174
- J Clin Neurol.
- 2018 Oct;14(4):472-477.
- doi: 10.3988/jcn.2018.14.4.472
BACKGROUND AND PURPOSE: Information processing speed is one of the most impaired cognitive functions in multiple sclerosis (MS). There are two tests widely used for evaluating information processing speed: the... -
- CITED
-
- Close
- SHARE
-
- Close
